[Federal Register Volume 84, Number 112 (Tuesday, June 11, 2019)]
[Notices]
[Pages 27144-27146]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12291]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-1112.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Opioid Drugs in Maintenance and Detoxification
Treatment of Opioid Dependence--42 CFR Part 8 (OMB No. 0930-0206) and
Opioid Treatment Programs (OTPs)--Extension
42 CFR part 8 establishes a certification program managed by
SAMHSA's Center for Substance Abuse Treatment (CSAT). The regulation
requires that Opioid Treatment Programs (OTPs) be certified.
``Certification'' is the process by which SAMHSA determines that an OTP
is qualified to provide opioid treatment under the Federal opioid
treatment standards established by the Secretary of Health and Human
Services. To become certified, an OTP must be accredited by a SAMHSA-
approved accreditation body. The regulation also provides standards for
such services as individualized treatment planning, increased medical
supervision, and assessment of patient outcomes. This submission seeks
continued approval of the information collection requirements in the
regulation and of the forms used in implementing the regulation.
SAMHSA currently has approval for the Application for Certification
to Use Opioid Drugs in a Treatment Program Under 42 CFR 8.11 (Form SMA-
162); the Application for Approval as Accreditation Body Under 42 CFR
8.3(b) (Form SMA-163); and the Exception Request and Record of
Justification Under 42 CFR 8.12 (Form SMA-168), which may be used on a
voluntary basis by physicians when there is a patient care situation in
which the physician must make a treatment decision that differs from
the treatment regimen required by the regulation. Form SMA-168 is a
simplified, standardized form to facilitate the documentation, request,
and approval process for exceptions.
SAMHSA believes that the recordkeeping requirements in the
regulation are customary and usual practices within the medical and
rehabilitative communities and has not calculated a response burden for
them. The recordkeeping requirements set forth in 42 CFR 8.4, 8.11 and
8.12 include maintenance of the following: 5-year retention by
accreditation bodies of certain records pertaining to accreditation;
documentation by an OTP of the following: A patient's medical
examination when admitted to treatment, A patient's history, a
treatment plan, any prenatal support provided the patient,
justification of unusually large initial doses, changes in a patient's
dosage schedule, justification of unusually large daily doses, the
rationale for decreasing a patient's clinic attendance, and
documentation of physiologic dependence.
The rule also includes requirements that OTPs and accreditation
organizations disclose information. For example, 42 CFR 8.12(e)(1)
requires that a physician explain the facts concerning the use of
opioid drug treatment to each patient. This type of disclosure is
considered to be consistent with the common medical practice and is not
considered an additional burden. Further, the rule requires, under Sec.
8.4(i)(1) that accreditation organizations shall make public their fee
structure; this type of disclosure is standard business practice and is
not considered a burden.
The tables that follow summarize the annual reporting burden
associated with the regulation, including burden associated with the
forms. There are no changes being made to the forms.
[[Page 27145]]
Estimated Annual Reporting Requirement Burden for Accreditation Bodies
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Responses/ Total Hours/
42 CFR citation Purpose respondents respondent responses response Total hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
8.3(b)(1-11).......................... Initial approval (SMA-163)...... 1 1 1 6.0 6
8.3(c)................................ Renewal of approval (SMA-163)... 2 1 2 1.0 2
8.3(e)................................ Relinquishment notification..... 1 1 1 0.5 0.5
8.3(f)(2)............................. Non-renewal notification to 1 90 90 0.1 9
accredited OTPs.
8.4(b)(1)(ii)......................... Notification to SAMHSA for 2 2 4 1.0 4
seriously noncompliant OTPs.
8.4(b)(1)(iii)........................ Notification to OTP for serious 2 10 20 1.0 20
noncompliance.
8.4(d)(1)............................. General documents and 6 5 30 0.5 15
information to SAMHSA upon
request.
8.4(d)(2)............................. Accreditation survey to SAMHSA 6 75 450 0.02 9
upon request.
8.4(d)(3)............................. List of surveys, surveyors to 6 6 36 0.2 7.2
SAMHSA upon request.
8.4(d)(4)............................. Report of less than full 6 5 30 0.5 15
accreditation to SAMHSA.
8.4(d)(5)............................. Summaries of Inspections........ 6 50 300 0.5 150
8.4(e)................................ Notifications of Complaints..... 12 6 72 0.5 36
8.6(a)(2) and (b)(3).................. Revocation notification to 1 185 185 0.3 55.5
Accredited OTPs.
8.6(b)................................ Submission of 90-day corrective 1 1 1 10 10.0
plan to SAMHSA.
8.6(b)(1)............................. Notification to accredited OTPs 1 185 185 0.3 55.0
of Probationary Status.
-------------------------------------------------------------------------------
Subtotal.......................... ................................ 54 .............. 1,407 .............. 394.20
--------------------------------------------------------------------------------------------------------------------------------------------------------
Estimated Annual Reporting Requirement Burden for Opioid Treatment Programs
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Responses/ Total Hours/
42 CFR citation Purpose respondents respondent responses response Total hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
8.11(b)............................... Renewal of approval (SMA-162)... 386 1 386 0.15 57.9
8.11(b)............................... Relocation of Program (SMA-162). 35 1 35 1.17 40.95
8.11(e)(1)............................ Application for provisional 42 1 42 1 42.00
certification.
8.11(e)(2)............................ Application for extension of 30 1 30 0.25 7.50
provisional certification.
8.11(f)(5)............................ Notification of sponsor or 60 1 60 0.1 6.00
medical director change (SMA-
162).
8.11(g)(2)............................ Documentation to SAMHSA for 1 1 1 1 1.00
interim maintenance.
8.11(h)............................... Request to SAMHSA for Exemption 1,200 20 24,000 0.07 1,680
from 8.11 and 8.12 (including
SMA-168).
8.11(i)(1)............................ Notification to SAMHSA Before 10 1 10 0.25 2.5
Establishing Medication Units
(SMA-162).
8.12(j)(2)............................ Notification to State Health 1 20 20 0.33 6.6
Officer When Patient Begins
Interim Maintenance.
8.24.................................. Contents of Appellant Request 2 1 2 0.25 .50
for Review of Suspension.
8.25(a)............................... Informal Review Request......... 2 1 2 1.00 2.00
8.26(a)............................... Appellant's Review File and 2 1 2 5.00 10.00
Written Statement.
8.28(a)............................... Appellant's Request for 2 1 2 1.00 2.00
Expedited Review.
8.28(c)............................... Appellant Review File and 2 1 2 5.00 10.00
Written Statement.
-------------------------------------------------------------------------------
Subtotal.......................... ................................ 1,775 .............. 24,594 .............. 1868.95
-------------------------------------------------------------------------------
Total......................... ................................ 1,829 .............. 26,001 .............. 2,263.15
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 27146]]
Send comments to Janet Heekin, SAMHSA Reports Clearance Officer,
Room 15E21-B, 5600 Fishers Lane, Rockville, MD 20850 OR email her a
copy at [email protected]. Written comments should be
received within 60 days of this notice.
Dated: June 6, 2019.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2019-12291 Filed 6-10-19; 8:45 am]
BILLING CODE 4162-20-P